-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Overweight on Amrize, Lowers Price Target to $58

Benzinga·07/08/2026 13:24:15
Listen to the news
Wells Fargo analyst Timna Tanners maintains Amrize (NYSE:AMRZ) with a Overweight and lowers the price target from $65 to $58.